Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Tolerability of Etanercept in Alzheimer's Disease (STEADI-09)

This study has been completed.
Sponsor:
Collaborators:
Hampshire Hospitals NHS Foundation Trust
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by (Responsible Party):
University of Southampton
ClinicalTrials.gov Identifier:
NCT01068353
First received: February 10, 2010
Last updated: April 22, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)